[1]
Piasecki, A. 2022. Non-vitamin K antagonist oral anticoagulants (NOAC) in nonvalvular atrial fibrillation – in-group comparison. Prospects in Pharmaceutical Sciences. 20, 1 (Jul. 2022), 26–31. DOI:https://doi.org/10.56782/pps.36.